Coronavirus vaccination drive for 18+ fails to take off in Assam

This was due to non-receipt of vaccine supply from the Centre

Coronavirus vaccine, covid-19, vaccination
Press Trust of India Guwahati
1 min read Last Updated : May 01 2021 | 4:04 PM IST

The Assam government could not rollout the third phase of the COVID-19 vaccination drive for people in the 18-44 age group on Saturday due to non-receipt of vaccine supply from the Centre, a top NHM official said here.

The process for the third phase of vaccination, as part of the nationwide drive to inoculate younger people, "will commence from the moment the corresponding number of vaccines are received from the Government of India", National Health Mission director S Laxmanan told PTI.

The Centre has sanctioned five lakh COVID-19 vaccines for the 18+ agwe group and the process for securing them is in progress, Laxmanan informed.

Assam Health Minister Dr. Himanta Biswa Sarma has tweeted, "Assam gets 5 lakh + #COVID19Vaccine by GOI (371480 Covishield; 128830 Covaxin) for 18+ people. We're procuring it immediately through funds of Assam Arogya Nidhi."

"Our vaccination will be FREE FOR all citizens", Sarma added.

However, the ongoing inoculation process for those above the age of 44 was continuing in Assam, the NHM Mission director said.

As many as 24,66,321 people have been vaccinated in the state so far, Laxmanan said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 01 2021 | 3:58 PM IST

Next Story